Page last updated: 2024-10-21

3,4-methylenedioxyamphetamine and Epidermolysis Bullosa

3,4-methylenedioxyamphetamine has been researched along with Epidermolysis Bullosa in 1 studies

3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.

Epidermolysis Bullosa: Group of genetically determined disorders characterized by the blistering of skin and mucosae. There are four major forms: acquired, simple, junctional, and dystrophic. Each of the latter three has several varieties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freeze, BM1

Other Studies

1 other study available for 3,4-methylenedioxyamphetamine and Epidermolysis Bullosa

ArticleYear
Sharing: brief life.
    Nursing, 1979, Volume: 9, Issue:4

    Topics: Epidermolysis Bullosa; Female; Humans; Infant, Newborn; Love

1979